{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:33:55Z","timestamp":1793226835191,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.actbio.2026.10.042","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:43:49Z","timestamp":1792770229000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetically reprogrammed exosomes for targeted prostate cancer immunotherapy"],"prefix":"10.1016","author":[{"given":"Guoyun","family":"Kao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3622-9388","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1099-733X","authenticated-orcid":false,"given":"Jianfei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhefu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5639-4884","authenticated-orcid":false,"given":"Angela","family":"Albanese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8530-7244","authenticated-orcid":false,"given":"Paul M.","family":"Seidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek K.","family":"Pinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3132-8557","authenticated-orcid":false,"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.actbio.2026.10.042_bib0001","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.actbio.2026.10.042_bib0002","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.actbio.2026.10.042_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118274","article-title":"Targeting prostate cancer with site-specific antibody-drug conjugates enabled by tandemly fused ADP-ribosyl cyclases","volume":"189","author":"Zhang","year":"2025","journal-title":"Biomed. PharmacOther"},{"issue":"13","key":"10.1016\/j.actbio.2026.10.042_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202518329","article-title":"Synthesis of bispecific conjugates by ADP-ribosyl cyclases","volume":"13","author":"Kim","year":"2026","journal-title":"Adv. Sci."},{"issue":"17\u201318","key":"10.1016\/j.actbio.2026.10.042_bib0005","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1101\/gad.315739.118","article-title":"Genetics and biology of prostate cancer","volume":"32","author":"Wang","year":"2018","journal-title":"Genes Dev."},{"issue":"14","key":"10.1016\/j.actbio.2026.10.042_bib0006","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/acs.biochem.0c00046","article-title":"Rational design of a humanized antibody inhibitor of cathepsin B","volume":"59","author":"Dai","year":"2020","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.actbio.2026.10.042_bib0007","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0959-8049(98)00273-1","article-title":"Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue","volume":"35","author":"Friedrich","year":"1999","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.actbio.2026.10.042_bib0008","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.semnuclmed.2016.07.002","article-title":"Diagnostic and therapeutic strategies for prostate cancer","volume":"46","author":"Nguyen-Nielsen","year":"2016","journal-title":"Semin. Nucl. Med."},{"issue":"7","key":"10.1016\/j.actbio.2026.10.042_bib0009","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s11864-024-01215-2","article-title":"Metastatic castration-resistant prostate cancer: advances in treatment and symptom management","volume":"25","author":"Kulasegaran","year":"2024","journal-title":"Curr. Treat. Options. Oncol."},{"key":"10.1016\/j.actbio.2026.10.042_bib0010","series-title":"Systemic Drug Delivery Strategies: Volume 2 of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy","author":"Amiji","year":"2021"},{"issue":"7","key":"10.1016\/j.actbio.2026.10.042_bib0011","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.bbagen.2012.03.017","article-title":"Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials","volume":"1820","author":"Vlassov","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.actbio.2026.10.042_bib0012","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41467-025-67661-0","article-title":"A versatile platform for chemical engineering of exosomes empowered by ADP-ribosyl cyclases","volume":"17","author":"Zhang","year":"2026","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.actbio.2026.10.042_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201802896","article-title":"Exosome biochemistry and advanced nanotechnology for next-generation theranostic platforms","volume":"31","author":"Yang","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2026.10.042_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114425","article-title":"Preclinical assessment of genetically modified exosomes for colorectal cancer immunotherapy","volume":"389","author":"Hoang","year":"2026","journal-title":"J. Contr. Rel."},{"key":"10.1016\/j.actbio.2026.10.042_bib0015","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.2147\/IJN.S264498","article-title":"Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications","volume":"15","author":"Zhang","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.actbio.2026.10.042_bib0016","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ymthe.2025.01.025","article-title":"Genetically reprogrammed exosomes for immunotherapy of acute myeloid leukemia","volume":"33","author":"Zhang","year":"2025","journal-title":"J. Am. Soc. Gene Therap."},{"key":"10.1016\/j.actbio.2026.10.042_bib0017","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ymeth.2019.09.017","article-title":"Reprogramming extracellular vesicles with engineered proteins","volume":"177","author":"Shi","year":"2020","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.actbio.2026.10.042_bib0018","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7150\/thno.21945","article-title":"Exosome theranostics: biology and translational medicine","volume":"8","author":"He","year":"2018","journal-title":"Theranostics"},{"issue":"34","key":"10.1016\/j.actbio.2026.10.042_bib0019","doi-asserted-by":"crossref","first-page":"9303","DOI":"10.1039\/D0SC01795G","article-title":"A poly-ADP-ribose polymer-based antibody-drug conjugate","volume":"11","author":"Shi","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.actbio.2026.10.042_bib0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu Rev. Cell Dev. Biol."},{"key":"10.1016\/j.actbio.2026.10.042_bib0021","doi-asserted-by":"crossref","first-page":"9355","DOI":"10.2147\/IJN.S281890","article-title":"Advances in exosome-based drug delivery and tumor targeting: from tissue distribution to intracellular fate","volume":"15","author":"Shao","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.actbio.2026.10.042_bib0022","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/aps.2017.12","article-title":"Engineering exosomes as refined biological nanoplatforms for drug delivery","volume":"38","author":"Luan","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.actbio.2026.10.042_bib0023","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/acs.molpharmaceut.8b00901","article-title":"Exosome as a novel shuttle for delivery of therapeutics across biological barriers","volume":"16","author":"Das","year":"2019","journal-title":"Mol. Pharmaceutic."},{"issue":"9","key":"10.1016\/j.actbio.2026.10.042_bib0024","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41551-021-00792-z","article-title":"Amelioration of systemic inflammation via the display of two different decoy protein receptors on extracellular vesicles","volume":"5","author":"Gupta","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"5","key":"10.1016\/j.actbio.2026.10.042_bib0025","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.ymthe.2021.01.020","article-title":"A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties","volume":"29","author":"Dooley","year":"2021","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.actbio.2026.10.042_bib0026","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/stcltm\/szae027","article-title":"Exploring the clinical transition of engineered exosomes designed for intracellular delivery of therapeutic proteins","volume":"13","author":"Kim","year":"2024","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.actbio.2026.10.042_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121129","article-title":"Expanding the toolbox of exosome-based modulators of cell functions","volume":"277","author":"Cheng","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.10.042_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.impact.2020.100261","article-title":"Exosome engineering: current progress in cargo loading and targeted delivery","volume":"20","author":"Fu","year":"2020","journal-title":"NanoImpact"},{"issue":"1","key":"10.1016\/j.actbio.2026.10.042_bib0029","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41565-017-0012-z","article-title":"Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression","volume":"13","author":"Pi","year":"2018","journal-title":"Nat. Nanotechnol."},{"issue":"7659","key":"10.1016\/j.actbio.2026.10.042_bib0030","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2026.10.042_bib0031","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1016\/j.ymthe.2022.06.013","article-title":"Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes","volume":"30","author":"Cheng","year":"2022","journal-title":"J. Am. Soc. Gene Therap."},{"issue":"11","key":"10.1016\/j.actbio.2026.10.042_bib0032","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/jcbfm.2013.152","article-title":"Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats","volume":"33","author":"Xin","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.actbio.2026.10.042_bib0033","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42485-4","article-title":"Stem cells-derived exosomes alleviate neurodegeneration and Alzheimer's pathogenesis by ameliorating neuroinflamation, and regulating the associated molecular pathways","volume":"13","author":"Khan","year":"2023","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.actbio.2026.10.042_bib0034","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/mds.25978","article-title":"Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice","volume":"29","author":"Cooper","year":"2014","journal-title":"Mov. Disord."},{"issue":"48","key":"10.1016\/j.actbio.2026.10.042_bib0035","doi-asserted-by":"crossref","first-page":"16413","DOI":"10.1021\/jacs.8b10047","article-title":"Reprogramming exosomes as nanoscale controllers of cellular immunity","volume":"140","author":"Cheng","year":"2018","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.actbio.2026.10.042_bib0036","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ymthe.2019.11.020","article-title":"Genetically engineered cell-derived nanoparticles for targeted breast cancer immunotherapy","volume":"28","author":"Shi","year":"2020","journal-title":"J. Am. Soc. Gene Therap."},{"issue":"13","key":"10.1016\/j.actbio.2026.10.042_bib0037","first-page":"3192","article-title":"Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature","volume":"59","author":"Chang","year":"1999","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.actbio.2026.10.042_bib0038","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.4049\/jimmunol.155.4.1903","article-title":"Identification of heavy chain residues in a humanized anti-CD3 antibody important for efficient antigen binding and T cell activation","volume":"155","author":"Zhu","year":"1995","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.actbio.2026.10.042_bib0039","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1021\/acs.biochem.2c00718","article-title":"Synthesis of bispecific antibody conjugates using functionalized poly-ADP-ribose polymers","volume":"62","author":"Cheng","year":"2023","journal-title":"Biochemistry"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126007208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126007208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:14:33Z","timestamp":1793225673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126007208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"alternative-id":["S1742706126007208"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.10.042","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetically reprogrammed exosomes for targeted prostate cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.10.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}